Back to top
more

Fresenius Medical Care AG & Co. (FMS)

(Delayed Data from NYSE)

$21.33 USD

21.33
269,784

-0.08 (-0.37%)

Updated Jun 7, 2024 04:00 PM ET

After-Market: $21.33 0.00 (0.00%) 7:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (152 out of 248)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for FMS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

1 item in cart

View Cart/Checkout

Fresenius Medical Care AG & Co. KGaA [FMS]

Reports for Purchase

Showing records 121 - 140 ( 144 total )

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 121

08/02/2013

Company Report

Pages: 7

Mixed 2Q13 results; 2013 guidance appears challenging

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 122

07/02/2013

Company Report

Pages: 7

Fireworks start early as CMS proposed ESRD rule worse than expected

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 123

05/01/2013

Company Report

Pages: 7

Weak 1Q13 results; we see no reason to step in, maintain HOLD

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 124

02/27/2013

Company Report

Pages: 8

4Q12 results and 2013 guidance hits the mark

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 125

01/07/2013

Company Report

Pages: 6

Adjusting model to reflect stock split

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 126

01/07/2013

Company Report

Pages: 6

Adjusting model to reflect ADR ratio change

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 127

11/23/2012

Company Report

Pages: 6

Tweaking model; maintaining HOLD

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 128

11/01/2012

Company Report

Pages: 7

3Q12 results disappoint on the top and bottom line; maintaining HOLD

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 129

05/07/2012

Company Report

Pages: 6

FMS 1Q12 results inline with preannouncement

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 130

04/26/2012

Company Report

Pages: 6

FMS FMS preannounced 1Q12 results largely inline

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 131

02/22/2012

Company Report

Pages: 7

FMS 4Q highlights solid operating results; 2012 guidance inline

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 132

11/07/2011

Company Report

Pages: 6

FMS 3Q met our expectations

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 133

06/02/2011

Company Report

Pages: 10

Survey sees further opportunity to reduce patient costs; near-term margin expansion?

Provider: FELTL & COMPANY

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 134

05/09/2011

Company Report

Pages: 7

Solid 1Q results; second half of the year looks promising

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 135

01/14/2011

Company Report

Pages: 11

Facility survey: Changes are underway and more diverse than expected

Provider: FELTL & COMPANY

Analyst: HOERNEMANN J

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 136

01/04/2011

Company Report

Pages: 6

Eastern European acquisition looks expensive, but will likely be accretive

Provider: FELTL & COMPANY

Analyst: HOERNEMANN J

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 137

12/17/2010

Company Report

Pages: 7

Will Fresenius consolidate the state of Vermont?

Provider: FELTL & COMPANY

Analyst: HOERNEMANN J

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 138

12/15/2010

Company Report

Pages: 7

Transition relief? It?s possible, but we remain skeptical

Provider: FELTL & COMPANY

Analyst: HOERNEMANN J

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 139

11/03/2010

Company Report

Pages: 7

Services drive third quarter, choice to opt in expected given cost saving opportunity

Provider: FELTL & COMPANY

Analyst: HOERNEMANN J

Price: 25.00

Research Provided by a Third Party

Company: Fresenius Medical Care AG & Co. KGaA

Industry: Medical - Instruments

Record: 140

10/06/2010

Company Report

Pages: 6

Managed care survey indicates shift in dialysis provider contracts

Provider: FELTL & COMPANY

Analyst: HOERNEMANN J

Price: 25.00

Research Provided by a Third Party